These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15926117

  • 1. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
    Tentolouris N, Matsagura M, Psallas M, Chatzizacharias A, Fotia M, Arvanitis M, Katsilambros N.
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
    [Abstract] [Full Text] [Related]

  • 2. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [Abstract] [Full Text] [Related]

  • 3. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA, LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic value of QT dispersion for acute coronary syndrome in patients presenting with chest pain and nondiagnostic initial electrocardiograms.
    Pekdemir M, Karaca I, Cevik Y, Yanturali S, Ilkay E.
    Mt Sinai J Med; 2006 Sep; 73(5):813-7. PubMed ID: 17008945
    [Abstract] [Full Text] [Related]

  • 5. [Increase of the QT interval dispersion in diabetes mellitus].
    Lengyel C, Várkonyi T, Boda K, Fazekas T.
    Orv Hetil; 1997 Feb 09; 138(6):337-41. PubMed ID: 9082291
    [Abstract] [Full Text] [Related]

  • 6. [Value and circadian variations of QT dispersion in patients with diabetes mellitus and coronary artery disease].
    Bissinger A, Markuszewski L, Rosiak M.
    Pol Merkur Lekarski; 2008 Feb 09; 24(140):90-4. PubMed ID: 18634261
    [Abstract] [Full Text] [Related]

  • 7. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
    Radman A, Murín J, Bulas J, Reptová A, Ravingerová T, Mikes P, Kozliková K, Ghanem W, Jaber J, Baqi L.
    Vnitr Lek; 2003 Oct 09; 49(10):802-7. PubMed ID: 14682153
    [Abstract] [Full Text] [Related]

  • 8. The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients.
    Pogatsa G, Koltai MZ, Jermendy G, Simon J, Aranyi Z, Ballagi-Pordany G.
    Acta Med Hung; 2003 Oct 09; 49(1-2):39-51. PubMed ID: 1296186
    [Abstract] [Full Text] [Related]

  • 9. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G, Aronow WS, Ahn C, Sujata K, Saulle LN, Channamsetty V, Weiss MB.
    Am J Ther; 2006 Oct 09; 13(5):400-3. PubMed ID: 16988534
    [Abstract] [Full Text] [Related]

  • 10. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.
    Pharmacoepidemiol Drug Saf; 2007 Jul 09; 16(7):711-25. PubMed ID: 17551989
    [Abstract] [Full Text] [Related]

  • 11. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS, Aslam M, Naveed AK, Razi MS.
    Saudi Med J; 2006 Feb 09; 27(2):174-80. PubMed ID: 16501671
    [Abstract] [Full Text] [Related]

  • 12. QT dispersion in type 2 diabetic patients with altered diurnal blood pressure rhythm.
    Deyneli O, Ersöz HO, Yavuz D, Fak AS, Akalin S.
    Diabetes Obes Metab; 2005 Mar 09; 7(2):136-43. PubMed ID: 15715886
    [Abstract] [Full Text] [Related]

  • 13. Effects of transient myocardial ischemia on the QT interval in man.
    Kerr CR, Hacking A, Henning H.
    Can J Cardiol; 1987 Mar 09; 3(8):383-6. PubMed ID: 3427536
    [Abstract] [Full Text] [Related]

  • 14. [Predictor of early thrombolysis in acute coronary syndrome by estimation of the QT interval variability on 12 lead standard electrocardiogram].
    Gegeshidze ND, Tabukashvili RI, Tsikarishvili SSh, Pagava ZT, Mamaladze GT.
    Georgian Med News; 2005 Nov 09; (128):35-7. PubMed ID: 16369060
    [Abstract] [Full Text] [Related]

  • 15. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide).
    Klamann A, Sarfert P, Launhardt V, Schulte G, Schmiegel WH, Nauck MA.
    Eur Heart J; 2000 Feb 09; 21(3):220-9. PubMed ID: 10639304
    [Abstract] [Full Text] [Related]

  • 16. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration.
    Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, Chirkov YY, Zeitz CJ, Horowitz JD.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):304-10. PubMed ID: 17239711
    [Abstract] [Full Text] [Related]

  • 17. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT, Mehnert F, Rungby J, Johnsen SP.
    J Stroke Cerebrovasc Dis; 2012 Nov 23; 21(8):717-25. PubMed ID: 21536457
    [Abstract] [Full Text] [Related]

  • 18. Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.
    Danchin N, Charpentier G, Ledru F, Vaur L, Guéret P, Hanania G, Blanchard D, Lablanche JM, Genès N, Cambou JP.
    Diabetes Metab Res Rev; 2005 Nov 23; 21(2):143-9. PubMed ID: 15386810
    [Abstract] [Full Text] [Related]

  • 19. QT dispersion and myocardial viability in patients after acute myocardial infarction.
    Kosmala W, Przewlocka-Kosmala M, Halawa B.
    Int J Cardiol; 2004 Apr 23; 94(2-3):249-54. PubMed ID: 15093989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.